Author/Authors :
Michael G Hennerici، نويسنده , , Richard Kay، نويسنده , , Julien Bogousslavsky، نويسنده , , Gian Luigi Lenzi، نويسنده , , Marc Verstraete، نويسنده , , Jean Marc Orgogozo and for the ESTAT investigators، نويسنده ,
Abstract :
Background
Intravenous tissue plasminogen activator is the only approved specific treatment for acute ischaemic stroke. Ancrod, a natural defibrinogenating agent from snake venom, has proved to have a favourable effect when given within 3 h after an acute
